TRANSTHYRETIN AMYLOID CARDIOMYOPATHY
Clinical trials for TRANSTHYRETIN AMYLOID CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new TRANSTHYRETIN AMYLOID CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for TRANSTHYRETIN AMYLOID CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart drug switch: can a new pill boost key protein levels?
Disease control Recruiting nowThis study tests a drug called acoramidis in 50 adults with a heart condition called ATTR-CM, where a protein builds up and weakens the heart. Participants have already been taking a similar drug (tafamidis) and will switch to acoramidis for 6 months. The main goal is to see if a…
Matched conditions: TRANSTHYRETIN AMYLOID CARDIOMYOPATHY
Phase: PHASE4 • Sponsor: Bayer • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New heart drug targets sticky proteins in rare disease
Knowledge-focused Recruiting nowThis study is for people with a heart condition called ATTR-CM, where abnormal protein builds up in the heart and makes it stiff. Researchers are testing a new medicine called coramitug, which is designed to bind to that protein and help remove it. The study uses special PET/CT s…
Matched conditions: TRANSTHYRETIN AMYLOID CARDIOMYOPATHY
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC